A number of peer-reviewed publications relevant to immunofilaments research and development can be found below.

Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis

Weiss L, Weiden J, Dolen Y, Grad EM, van Dinther EAW, Schluck, M, Eggermont, LJ, van Mierlo G, Gileadi U, Bartolo-Ibars A, Raave R, Gorris MAJ, Maassen L, Verrijp K, Valente M, Deplancke B, Verdoes M, Benitez-Ribas D, Heskamp S, van Spriel A, Figdor CG, and Hammink R: Acs Nano 2023.

Dictating Phenotype, Function, and Fate of Human T Cells with Co-Stimulatory Antibodies Presented by Filamentous Immune Cell Mimics

Schluck M, Eggermont LJ, Weiden J, Popelier C, Weiss L, Pilzecker B, Kolder S, Heinemans A, Rodriguez Mogeda C, Verdoes M, Figdor CG and Hammink R.; Adv. Therap. 2022, DOI 2200019.

Semiflexible Immunobrushes Induce Enhanced T Cell Activation and Expansion:

Hammink R, Weiden J, Voerman D, Popelier C, Eggermont LJ, Schluck M, Figdor CG and Verdoes M.; ACS Appl. Mater. Interfaces, 2021, 13, 14, 16007.

Synthetic Semiflexible and Bioactive Brushes:

Voerman D, Schluck M, Weiden J, Joosten B, Eggermont LJ, van den Eijnde T, Ignacio B, Cambi A, Figdor CG, Kouwer PHJ, Verdoes M, Hammink R. and Rowan AE.; Biomacromolecules, 2019, 20, 2587.

Cytokine-functionalized Synthetic Dendritic Cells for T Cell Targeted Immunotherapies:

Eggermont LJ, Hammink R, Blank KG, Rowan AE, Tel J, and Figdor CG.; Adv. Therap, 2018, DOI1800021.

Controlling T-cell activation with synthetic dendritic cells using the multivalency effect:

Hammink, R, Mandal, S, Eggermont, L, Nooteboom, M, Willems, P, Tel J, Figdor CG, Blank K, and Rowan AE; ACS Omega, 2017, 2 (3), 937.

Affinity-Based Purification of Polyisocyanopeptide Bioconjugates:

Hammink R, Eggermont LJ, Zisis T, Tel J, Figdor CG, Rowan AE, and Blank KG.; Bioconj. Chem., 2017, 28 (10), 2560.

Polymer-Based Synthetic Dendritic Cells for Tailoring Robust and Multifunctional T Cell Responses:

Mandal S, Hammink R, Tel J, Eksteen-Akeroyd ZH, Rowan AE, Blank K, and Figdor CG; ACS Chem. Biol. 2015, 10 (2), 485.

Therapeutic nanoworms: towards novel synthetic dendritic cells for immunotherapy:

Mandal S, Eksteen-Akeroyd Z, Jacobs MJ, Hammink R, Koepf M, Lambeck A J, van Hest JCM, Wilson C J, Blank K, Figdor CG, and Rowan AE; Chem. Sci. 2013, 4 (11), 4168.